アステラス製薬

Astellas today announced that it has agreed on a memorandum of understanding (MoU) with the Korea Institute of Startup and Entrepreneurship Development, an umbrella organization of the Ministry of SMEs and Startups, a Korean Government Agency, for the operation of the Partnership with Global Companies Program, which aims to identify Korean drug-discovery startups and support their business growth and global expansion. Read more: https://lnkd.in/dddgQA6r #OpenInnovation #SakuLab

The 20th term Annual #ShareholdersMeeting was held, and more shareholders attended than last year. We have adopted a hybrid remote attendance-type virtual shareholders meeting. This type of meeting allows shareholders to exercise their voting rights and ask questions online. This type is an #AdvancedInitiative adopted by few companies out of more than 2,000 listed companies in Tokyo Stock Exchange that hold their annual shareholders meeting in June 2025. The "Notice of Resolution,” "Results of Exercise of Voting Rights,” "Questions and Answers from Shareholders” and “Annual Shareholders Meeting Script” have been published on our corporate website. Click here to learn more: https://bit.ly/40kvoyg #HybridRemoteAttendanceType #VirtualShareholdersMeeting

In drug development, clinical trials are essential to determine if an experimental treatment is safe and effective in treating a specific condition or disease. To help patients and their families learn more, we recently enhanced our clinical trials website to provide more information and an improved user experience. This website features educational resources about the clinical trial process, detailed information about our clinical trials at Astellas, and patient engagement communication options. See the refreshed site at: https://bit.ly/452W4Go  

We are excited to share that Astellas has been selected for a government project designed to strengthen drug discovery efforts in Japan, specifically for our SakuLab™-Tsukuba initiatives. With this support, we will enhance the SakuLab-Tsukuba facilities to empower start-ups in their research and host a variety of events to connect diverse stakeholders, fostering a vibrant and collaborative life-science ecosystem. Led by the Ministry of Health, Labour and Welfare, this Drug Discovery Cluster Campus Development Project launches this year to support existing drug discovery clusters. By providing essential funding, the project seeks to nurture a robust ecosystem that accelerates the development of innovative new drugs. At Astellas, we are committed to delivering VALUE for patients through open innovation and collaboration with external partners in the life science. We designed SakuLab as a space where science innovators can access to Astellas’ expertise and capabilities to turn their ideas into groundbreaking healthcare solutions. Through our open-innovation activities, including SakuLab, we drive innovation forward. #ChangingTomorrow #OpenInnovation #SakuLab

As a thriving life-science hub, #Massachusetts offers an unparalleled ecosystem for innovation.      Tadaaki Taniguchi, our Chief Research and Development Officer, shared his insights with the Boston Business Journal into Astellas’ growing presence and extensive partnerships in the area. He also discussed how collaboration is accelerating the delivery of next-generation therapies to patients.     Read more: https://lnkd.in/g2xPXKs5    *You may need to register to read the article.      #ChangingTomorrow  

We are thrilled to announce that Nick Eshkenazi, our Chief Digital & Transformation Officer (CDTO), has been recognized with the prestigious Digital Transformation Champion award at the Digital Nation Awards held on June 24, 2025 in Sydney, Australia. The Digital Nation Awards celebrate C-suite executives who drive meaningful change within their organizations through visionary leadership and strategic execution of digital transformation initiatives.  Nick and his team’s dedication to leveraging technology to enhance stakeholders’ experiences, optimize operations, and drive enterprise-wide digital transformation has truly set him apart.   Thank you to iTnews, Digital Nation Australia , and ADAPT Digital Edge for this incredible recognition.    You can read more about the award: https://lnkd.in/gGZyGneB #DigitalNationAwards #DigitalTransformation #leadership #innovation #ProudMoment

Peut-on donner ses organes à tout âge ? L’apparence du corps est-elle préservée après un don d’organes ? Peut-on choisir quels organes donner ou non ? 🤝 Du 23 au 29 juin, #Astellas s’engage aux côtés de Doctolib pour répondre à ces questions, et sensibiliser au don d’organes, via une campagne diffusée directement sur la plateforme. ➡️ L’enjeu est simple mais essentiel : encourager chacun à exprimer sa position et favoriser le dialogue avec ses proches. 🙌 Avec la participation de la SFT - Société Francophone de Transplantation, Association Trans-Forme, TRANSHEPATE, FRANCE REIN et Fondation Greffe de Vie, cette initiative s’inscrit dans notre volonté commune de faire progresser la culture du don, parce qu’un mot peut sauver jusqu’à 7 vies. #DonDOrganes

As we look to the future of #PatientCentricity, one thing is clear. It is no longer enough to develop medicines for patients — we must develop them with patients.    We’re advocating for patients to have a seat at every table where healthcare decisions are made. This includes early research to real-world delivery.    So, as #PatientCentricityMonth2025 ends, we're reaffirming our commitment to creating space, structure and support for patients to participate. Because their insights don’t just add value. They define it.    #PATIENTSAREWHY 

For HCPs: We’re attending #RCOG2025 and hope to see you there. Improving access to appropriate support and care for people experiencing menopause has always been a priority for Astellas and we can’t do it alone. We’re looking forward to meeting with leading experts in women’s health to advance the conversation around breaking the barriers to menopause care. It’s essential that we better understand these barriers and unmet needs to accelerate the care pathway and improve outcomes for those experiencing this important life stage. We look forward to insightful discussions. Royal College of Obstetricians and Gynaecologists | RCOG #WomensHealth #menopause

🎧 Don d’organes : une parole peut suffire à sauver jusqu’à 7 vies. Et pourtant, chaque jour en France, 2 à 3 patients meurent faute d’un organe disponible. À l’occasion de la Journée nationale de réflexion sur le don d’organes et la greffe le 22 juin, #Astellas Pharma France lance une campagne sonore inédite sur les ondes et les plateformes audios : ➡️ « Don d’organes : et si on en parlait ? », à écouter ici : https://lnkd.in/epMefJYD Une série de chroniques audios, diffusées librement sur toutes les radios et web radios françaises pour briser le silence grâce à des témoignages de receveurs, de donneurs, de proches et de soignants. 🎙 Avec le soutien de l’AGENCE DE LA BIOMEDECINE et de nos partenaires associatifs Francerein, Association Trans-Forme, TRANSHEPATE, SFT - Société Francophone de Transplantation, cette campagne s’adresse à chacun de nous : en parler, c’est sauver des vies. #DonDOrganes